Crinetics Pharmaceuticals, Inc. (CRNX)
NASDAQ: CRNX · Real-Time Price · USD
35.57
-0.25 (-0.70%)
At close: Mar 20, 2026, 4:00 PM EDT
36.00
+0.43 (1.21%)
After-hours: Mar 20, 2026, 6:49 PM EDT

Crinetics Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
3,7244,4494,7512,4269861,352
Market Cap Growth
17.34%-6.37%95.88%146.02%-27.09%190.40%
Enterprise Value
2,7453,4633,4421,915653.551,022
Last Close Price
35.5746.5551.1335.5818.3028.41
PE Ratio
--9.40-13.86-9.64-5.81-10.15
PS Ratio
483.94578.084572.96604.45208.141254.39
PB Ratio
3.434.483.594.503.124.07
P/TBV Ratio
3.374.413.123.833.013.29
P/FCF Ratio
--11.60-20.30-14.00-8.44-15.19
P/OCF Ratio
--11.77-20.64-14.39-8.56-15.26
EV/Sales Ratio
356.68449.983312.62477.12137.97947.68
EV/EBITDA Ratio
--6.75-10.24-8.64-3.92-9.57
EV/EBIT Ratio
--6.70-10.16-8.60-3.89-9.49
EV/FCF Ratio
--9.03-14.71-11.05-5.59-11.48
Debt / Equity Ratio
0.040.040.030.090.010.01
Debt / EBITDA Ratio
-0.09-0.09-0.15-0.23-0.02-0.03
Debt / FCF Ratio
-0.13-0.13-0.22-0.30-0.03-0.04
Net Debt / Equity Ratio
-0.99-0.99-0.98-0.94-1.05-1.00
Net Debt / EBITDA Ratio
1.911.913.882.291.993.10
Net Debt / FCF Ratio
2.552.555.572.932.843.71
Asset Turnover
0.010.010.000.010.010.00
Inventory Turnover
1.061.06----
Quick Ratio
12.0912.0922.6912.7112.0620.86
Current Ratio
12.3212.3223.0413.0712.4521.55
Return on Equity (ROE)
-40.17%-40.17%-32.02%-50.16%-50.57%-42.98%
Return on Assets (ROA)
-40.37%-40.37%-32.74%-45.08%-47.75%-40.30%
Return on Invested Capital (ROIC)
-2019.92%-2019.92%-978.61%-1373.95%7581.03%-4172.07%
Return on Capital Employed (ROCE)
-42.78%-42.78%-34.47%-48.61%-50.91%-42.40%
Earnings Yield
-12.49%-10.63%-7.22%-10.37%-17.21%-9.86%
FCF Yield
-10.30%-8.62%-4.93%-7.14%-11.85%-6.58%
Buyback Yield / Dilution
-1.01%-0.91%-21.67%-16.15%-12.37%-18.69%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q